posted
roger that; seems to be several players in this story, though...DNA, CLEG and whoever makes unreleased "Revlimid"; Dusty's hot on it and I'm way interested...pretty strong headline on news release. btw, lovin HISC--that's one of your babies, right?
-------------------- Nashoba Holba Chepulechi Adventures in microcapitalism...
IP: Logged |
posted
yeah I know I'm just watching I'm playing NNVC, i'm still in with free shares, hade bought a long time ago at 0.20 and so just holding onto it. I just like watching the ones that run in one day, dont have time to play them.
IP: Logged |
posted
UPDATE 1-Viragen drug shows potential to fight bird flu Fri Nov 18, 2005 04:38 PM ET (Adds details, stock move) NEW YORK, Nov 18 (Reuters) - Viragen Inc. (VRA.A: Quote, Profile, Research) on Friday said preliminary in-vitro studies of its drug Multiferon showed that it was effective against the virus that causes avian flu, sending shares of the biotech company up more than 80 percent.
The early-stage studies, conducted by the not-for-profit Southern Research Institute, showed that Multiferon was more active than other products against the H5N1 influenza virus.
Viragen said it believes the drug, sold in 10 markets outside the United States for infectious diseases and cancer, may have "utility" against the virus, and that it is a prime candidate worthy of further evaluation.
The company said it included the results to supplement a patent application it filed with the United Kingdom in February 2004 to cover the use of its product in treating and preventing avian flu in humans.
Shares of the Plantation, Florida-based company rose 29 cents to close at 65 cents on the American Stock Exchange.